Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck
Article
Perez, CA, Song, H, Raez, LE et al. (2012). Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck
. 48(9), 887-892. 10.1016/j.oraloncology.2012.03.020
Perez, CA, Song, H, Raez, LE et al. (2012). Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck
. 48(9), 887-892. 10.1016/j.oraloncology.2012.03.020